Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.

scientific article published on December 2000

Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1542/PEDS.106.6.E77
P698PubMed publication ID11099620
P5875ResearchGate publication ID12227577

P50authorStephen M GrahamQ63493477
P2093author name stringT E Taha
R L Broadhead
J D Chiphangwi
D R Hoover
N I Kumwenda
P G Miotti
D Markakis
G N Liomba
L van Der Hoeven
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectmaternal healthQ6786626
P304page(s)E77
P577publication date2000-12-01
P1433published inPediatricsQ7159238
P1476titleMorbidity among human immunodeficiency virus-1-infected and -uninfected African children
P478volume106

Reverse relations

cites work (P2860)
Q37591893A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants
Q34410400A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South A
Q22252385AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection
Q36916297Acceptance of HIV testing for children ages 18 months to 13 years identified through voluntary, home-based HIV counseling and testing in western Kenya
Q43063351Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people
Q35065640Assessment of the epidemiology and burden of measles in Southern Mozambique
Q36279151Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009.
Q26749153Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa
Q24244620Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection
Q24250276Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection
Q40561063Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV
Q40724523Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
Q57531078Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children
Q37226114Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa
Q35452458Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi
Q37411773Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review
Q35937990Epidemiology of Respiratory Disease in Malawi
Q36177513Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection
Q35901112Growth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand
Q35077724HIV-1 infection and AIDS.
Q33308717HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization
Q45273875Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth
Q36055407High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody
Q38457057Home-based care for orphaned children infected with HIV/AIDS in Uganda.
Q37386643Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers
Q37425515Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination
Q33972150Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda
Q45016203Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India
Q33624111Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency
Q37286746Impact of multi-micronutrient supplementation on growth and morbidity of HIV-infected South African children
Q30370395Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.
Q46988948Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART
Q33624926Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regiona
Q28077904Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants
Q34231039Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival
Q34154719Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study
Q39569701Meeting international goals in child survival and HIV/AIDS.
Q35729737Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in Malawi
Q37798996Mother-to-child transmission of HIV-1 in sub-Saharan Africa: Past, present and future challenges
Q45200255Mother-to-child transmission of HIV: a global perspective
Q38868088Multiple micronutrient supplementation does not reduce diarrhoea morbidity in Ugandan HIV-infected children: a randomised controlled trial
Q37087787PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges
Q34942527Paediatric HIV in 2002--a treatable and preventable infection
Q26747400Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children
Q40443605Presenting symptoms and signs in children referred for palliative care in Malawi
Q35101274Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe
Q46472414Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics
Q39037971Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis
Q33987771Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa
Q31020587Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
Q34511504Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy
Q54533393Should treatment be started among all HIV-infected children and then stopped?
Q36504397Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo
Q38928659The impact of HIV infection on childhood pneumonia: comparison between developed and developing regions.
Q39982387To treat or not to treat? No longer a question
Q37290917Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
Q35788052Triple nucleoside reverse transcriptase inhibitor therapy in children
Q30397919Uptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive study
Q57019179Viral Sepsis in Children
Q43049174Viral coinfections among African children infected with human immunodeficiency virus type 1.
Q46420805nef gene sequence variation among HIV-1-infected African children

Search more.